Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-076479
Filing Date
2025-08-12
Accepted
2025-08-12 07:27:38
Documents
15
Effectiveness Date
2025-08-12

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2522667d1_s8.htm S-8 52162
2 EXHIBIT 5.1 tm2522667d1_ex5-1.htm EX-5.1 8795
3 EXHIBIT 23.1 tm2522667d1_ex23-1.htm EX-23.1 1991
4 EX-FILING FEES tm2522667d1_ex-filingfees.htm   iXBRL EX-FILING FEES 16450
5 GRAPHIC tm2522667d1_ex5-1img01.jpg GRAPHIC 11769
  Complete submission text file 0001104659-25-076479.txt   216295

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2522667d1_ex-filingfees_htm.xml XML 5047
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-289509 | Film No.: 251204023
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)